163 related articles for article (PubMed ID: 31135241)
1. Trends in incidence, treatment and survival of borderline ovarian tumors in the Netherlands: a nationwide analysis.
Schuurman MS; Timmermans M; van Gorp T; de Vijver KKV; Kruitwagen RFPM; Lemmens VEPP; van der Aa MA
Acta Oncol; 2019 Jul; 58(7):983-989. PubMed ID: 31135241
[No Abstract] [Full Text] [Related]
2. Risk of specific types of ovarian cancer after borderline ovarian tumors in Denmark: A nationwide study.
Hannibal CG; Frederiksen K; Vang R; Kurman RJ; Kjaer SK
Int J Cancer; 2020 Aug; 147(4):990-995. PubMed ID: 31930502
[TBL] [Abstract][Full Text] [Related]
3. Borderline ovarian tumors: French guidelines from the CNGOF. Part 1. Epidemiology, biopathology, imaging and biomarkers.
Huchon C; Bourdel N; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101965. PubMed ID: 33160106
[TBL] [Abstract][Full Text] [Related]
4. Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands.
van Altena AM; Karim-Kos HE; de Vries E; Kruitwagen RF; Massuger LF; Kiemeney LA
Gynecol Oncol; 2012 Jun; 125(3):649-54. PubMed ID: 22370602
[TBL] [Abstract][Full Text] [Related]
5. Treatment patterns and associated factors in patients with advanced epithelial ovarian cancer: a population-based study.
Zijlstra M; Timmermans M; Fransen H; van der Aa M; Reyners A; Raijmakers N; van de Poll-Franse L
Int J Gynecol Cancer; 2019 Jul; 29(6):1032-1037. PubMed ID: 31263022
[TBL] [Abstract][Full Text] [Related]
6. Trends and characteristics of epithelial ovarian cancer in Japan between 2002 and 2015: A JSGO-JSOG joint study.
Machida H; Matsuo K; Yamagami W; Ebina Y; Kobayashi Y; Tabata T; Kanauchi M; Nagase S; Enomoto T; Mikami M
Gynecol Oncol; 2019 Jun; 153(3):589-596. PubMed ID: 30905436
[TBL] [Abstract][Full Text] [Related]
7. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
8. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level.
Baandrup L; Faber MT; Aalborg GL; Kjaer SK
Acta Obstet Gynecol Scand; 2021 Mar; 100(3):436-443. PubMed ID: 33010027
[TBL] [Abstract][Full Text] [Related]
9. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
10. Trends in incidence of borderline ovarian tumors in Denmark 1978-2006.
Hannibal CG; Huusom LD; Kjaerbye-Thygesen A; Tabor A; Kjaer SK
Acta Obstet Gynecol Scand; 2011 Apr; 90(4):305-12. PubMed ID: 21306323
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
[TBL] [Abstract][Full Text] [Related]
12. Incidence and treatment outcomes of ovarian sarcoma compared to epithelial ovarian cancer from the national cancer registry.
Ha HI; Cho SH; Lim J; Lee YJ; Yoo CW; Won YJ; Lim MC
Gynecol Oncol; 2021 Dec; 163(3):506-510. PubMed ID: 34602286
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival in women with borderline ovarian tumors: a population-based survey of borderline ovarian tumors in Sweden 1960-2007.
Kalapotharakos G; Högberg T; Bergfeldt K; Borgfeldt C
Acta Obstet Gynecol Scand; 2016 Apr; 95(4):473-9. PubMed ID: 26714557
[TBL] [Abstract][Full Text] [Related]
14. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
Chen RF; Li J; Zhu TT; Yu HL; Lu X
J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
[TBL] [Abstract][Full Text] [Related]
15. Nationwide population-based study of prevalence and trend of borderline ovarian tumors in the Republic of Korea.
Ouh YT; Kang D; Kim H; Lee JK; Hong JH
Sci Rep; 2021 May; 11(1):11158. PubMed ID: 34045639
[TBL] [Abstract][Full Text] [Related]
16. Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989-2015.
van der Hel OL; Timmermans M; van Altena AM; Kruitwagen RFPM; Slangen BFM; Sonke GS; van de Vijver KK; van der Aa MA
Eur J Cancer; 2019 Sep; 118():97-104. PubMed ID: 31326731
[TBL] [Abstract][Full Text] [Related]
17. Ovarian cancer in Switzerland: incidence and treatment according to hospital registry data.
Wieser S; Schmidt M; Kind AB; Heinzelmann-Schwarz VA
Swiss Med Wkly; 2018 Jul; 148():w14647. PubMed ID: 30141520
[TBL] [Abstract][Full Text] [Related]
18. Low-grade epithelial ovarian cancer: what a radiologist should know.
Elsherif S; Javadi S; Viswanathan C; Faria S; Bhosale P
Br J Radiol; 2019 Mar; 92(1095):20180571. PubMed ID: 30604635
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant platinum-based chemotherapy for borderline serous ovarian tumors with invasive implants.
Leary A; Petrella MC; Pautier P; Duvillard P; Uzan C; Tazi Y; Ledoux F; Gouy S; Morice P; Lhommé C
Gynecol Oncol; 2014 Jan; 132(1):23-7. PubMed ID: 24219980
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors.
Lu KH; Bell DA; Welch WR; Berkowitz RS; Mok SC
Cancer Res; 1998 Jun; 58(11):2328-30. PubMed ID: 9622067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
